Triterpene glycosides appear to act as competitive inhibitors for P-gp, multiple resistance-associated protein1 (MRP1), and Breast cancer resistance protein (BCRP) in cancer cells, or efflux pumps in bacteria (NorA) and fungi [156]. This evidence concerns the gene ABCG2 and cancer.